Fabio Puglisi

70PUBLICATIONS
341CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsPredictive and prognostic markersOrthodontics and dentofacial orthopaedicsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (70)

|Jun 12, 2026
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

|Apr 14, 2026
LC-MS/MS Method for Therapeutic Drug Monitoring of Abiraterone, Darolutamide, Apalutamide, Enzalutamide, and Metabolites in Prostate Cancer Patients.

Bianca Posocco, Diletta Pasin, Nicoletta De Cesaro

|Jan 26, 2026
Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial.

Giampaolo Bianchini, Luca Malorni, Roberta Caputo

|Dec 30, 2025
A New Model for Bone Health Management in Postmenopausal Early Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy-The Predict & Prevent Project.

Stefania Gori, Alessandra Fabi, Rossana Berardi

|Nov 26, 2025
Idiosyncratic Drug-Induced Liver Injury and Trastuzumab Deruxtecan in Breast Cancer: A Case Report.

Camilla Lisanti, Serena Della Rossa, Emma Zottarelli

|Nov 26, 2025
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer.

Riccardo Vida, Michele Bartoletti, Lucia Lerda

Pageof 12

Frequent Collaborators

15 joint publications

Lucia Del Mastro

12 joint publications

Lorenzo Gerratana

10 joint publications

Vincenzo Canzonieri

7 joint publications

Jerry Polesel